Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination

Journal:

Nature Communications

Published:

2026-04-10

DOI:

10.1038/s41467-026-71354-7

Affiliations:

12

Authors:

25

Go to article

Institutions	Authors	Share
Technical University of Munich (TUM), Germany	15.000000 15.000000	0.60
University of Natural Resources and Life Sciences, Vienna (BOKU), Austria	2.500000	0.10
University Hospital of Würzburg (UKW), JMU, Germany	2.250000	0.09
TUM University Hospital Klinikum rechts der Isar (MRI), Germany	1.000000	0.04
San Raffaele Scientific Institute, Italy	1.000000	0.04
Fred Hutchinson Cancer Center, United States of America (USA)	1.000000	0.04
DZIF Partner Site Munich, Germany	1.000000	0.04
Medical University of Vienna (MUW), Austria	0.500000	0.02
Fraunhofer Institute for Cell Therapy and Immunology (IZI), Germany	0.250000	0.01
NCT WERA, Germany	0.250000	0.01
Bavarian Cancer Research Center (BZKF), Germany	0.250000	0.01

Interested in Oncology and Carcinogenesis?